Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine Deaminase
1987 · New England Journal of Medicine · 446 citations
https://doi.org/10.1056/nejm198703053161005
M
Michael S. Hershfield
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
54
Citations
3
h-index
1
i10-index
Michael S. Hershfield is an academic researcher from Duke Medical Center. The author has contributed to research in topics: HIV/AIDS drug development and treatment & Biochemical and Molecular Research & Cell death mechanisms and regulation. The author has an h-index of 3, co-authored 5 publications.
Papers by this author
worksInduced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
2014 · Arthritis Research & Therapy · 262 citations
https://doi.org/10.1186/ar4500
New insights into adenosine‐receptor‐mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency
2004 · European Journal of Immunology · 122 citations
https://doi.org/10.1002/eji.200425738
Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
2015 · Journal of Allergy and Clinical Immunology · 266 citations
https://doi.org/10.1016/j.jaci.2015.10.034
Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency
2018 · Journal of Allergy and Clinical Immunology · 130 citations
https://doi.org/10.1016/j.jaci.2018.08.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat